Northern Trust
AYTU icon

Northern Trust’s AYTU BioPharma AYTU Stock Holding History

Northern Trust’s Portfolio AYTU Stock Details AYTU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$60K Buy
27,925
+8,756
+46% +$20.7K ﹤0.01% 4234
2026
Q1 		$52.3K Hold
19,169
– – ﹤0.01% 4237
2025
Q4 		$49.8K Buy
+19,169
New +$43K ﹤0.01% 4278
2024
Q4 		– Sell
-14,557
Closed -$34.2K – 4445
2024
Q3 		$34.2K Hold
14,557
– – ﹤0.01% 4271
2024
Q2 		$42.5K Sell
14,557
-7
-0% -$21 ﹤0.01% 4233
2024
Q1 		$44.3K Sell
14,564
-4
-0% -$11 ﹤0.01% 4246
2023
Q4 		$41.4K Hold
14,568
– – ﹤0.01% 4267
2023
Q3 		$39.3K Buy
+14,568
New +$25.5K ﹤0.01% 4221
2023
Q1 		– Sell
-2,330
Closed -$8.81K – 4582
2022
Q4 		$8.81K Hold
2,330
– – ﹤0.01% 4587
2022
Q3 		$9K Sell
2,330
-77
-3% -$584 ﹤0.01% 4648
2022
Q2 		$34K Sell
2,407
-25
-1% -$320 ﹤0.01% 4522
2022
Q1 		$53K Sell
2,432
-10
-0.4% -$249 ﹤0.01% 4521
2021
Q4 		$66K Sell
2,442
-13
-0.5% -$562 ﹤0.01% 4541
2021
Q3 		$141K Buy
2,455
+102
+4% +$7.65K ﹤0.01% 4309
2021
Q2 		$236K Sell
2,353
-8,304
-78% -$974K ﹤0.01% 4087
2021
Q1 		$1.62M Buy
10,657
+8,209
+335% +$1.3M ﹤0.01% 3361
2020
Q4 		$293K Buy
2,448
+115
+5% +$20.9K ﹤0.01% 3869
2020
Q3 		$555K Buy
2,333
+825
+55% +$212K ﹤0.01% 3582
2020
Q2 		$429K Buy
1,508
+1,403
+1,336% +$425K ﹤0.01% 3593
2020
Q1 		$32K Buy
105
+52
+98% +$10K ﹤0.01% 4019
2019
Q4 		$10K Hold
53
– – ﹤0.01% 4195
2019
Q3 		$13K Hold
53
– – ﹤0.01% 4177
2019
Q2 		$20K Hold
53
– – ﹤0.01% 4167
2019
Q1 		$18K Buy
+53
New +$13.2K ﹤0.01% 4140

Other funds holding AYTU

NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $177M AUM 91.13% 1-Year Est. Return
AIC
AWM Investment Company New York $1.15B AUM 201.65% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
CAM
Crown Advisors Management Larkspur, California $182M AUM 103.97% 1-Year Est. Return
DP
Diadema Partners Morristown, New Jersey $791M AUM 245.83% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

Northern Trust's AYTU Position: Q2 2026 in Review

Northern Trust increased its AYTU BioPharma (AYTU) stake by 46% in Q2 2026, buying an estimated $20.7K and bringing the position to 27,925 shares worth $60K. The position accounts for ﹤0.01% of the portfolio, ranked #4234.

Northern Trust first reported a position in AYTU in Q1 2019 and has held it in 24 quarters since. The position peaked at $1.62M in Q1 2021. 38 funds tracked by Wall St. Rank hold AYTU as of Q2 2026.

  • Northern Trust held 27,925 shares of AYTU BioPharma worth $60K as of Q2 2026.
  • Northern Trust bought 8,756 AYTU BioPharma shares in Q2 2026, an estimated $20.7K.
  • AYTU BioPharma made up ﹤0.01% of Northern Trust's portfolio in Q2 2026, its #4234 holding.
  • Northern Trust first reported a position in AYTU BioPharma in Q1 2019 and has held it in 24 quarters since.
  • Northern Trust's AYTU BioPharma position peaked at $1.62M in Q1 2021.
  • 38 funds tracked by Wall St. Rank held AYTU BioPharma as of Q2 2026.

Based on Northern Trust's 13F filing for Q2 2026, filed 13 Aug 2026.